Skip to content

Cardinal Health

US · CAH #429 by market cap Listed 1970
272.81 +0.47 +0.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
  • Total institutional ownership rose 0.2 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
90.46% +0.22pp
Institutions
1,781 -4
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund72.83%
Public Company5.15%
Hedge Fund4.22%
Private Company2.82%
Government Pension Fund2.60%
Sovereign Wealth Fund1.70%
Family Office/Trust0.33%
Insurance Company0.28%
Endowment Fund0.14%
Corporate Pension Plan0.16%
Other9.92%

Top holders as of 2026-09-30

BlackRock 11.06% · 25.57M sh
Vanguard Capital Management, LLC 7.16% · 16.55M sh
Vanguard Portfolio Management, LLC 5.86% · 13.54M sh
State Street Global Advisors 5.21% · 12.05M sh
Wellington Management Group 4.27% · 9.87M sh
Geode Capital Management, LLC 2.79% · 6.45M sh
UBS Asset Management 1.72% · 3.97M sh
WCM Investment Management 1.78% · 4.11M sh
Norges Bank Investment Management 1.61% · 3.73M sh
Morgan Stanley 1.44% · 3.32M sh
Invesco Ltd. 1.15% · 2.65M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 26 buys · 24 sells

NameRoleStake
Jason Hollar Chief Executive Officer 0.03%
Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment 0.03%
Ola Snow Former Chief Human Resources Officer 0.01%
Stephen Mason Chief Executive Officer of GMPD segment 0.01%
Patricia Hemingway Hall Independent Chairperson 0.00%
Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services 0.00%
Michelle Brennan Independent Director 0.00%
Jessica Mayer Chief Legal & Compliance Officer 0.00%
Anita Zielinski Senior VP of Finance & Chief Accounting Officer 0.00%
Sheri Edison Independent Director 0.00%
Valerie Pitteroff Chief Human Resources Officer 0.00%
Robert Azelby Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-18 Jason Hollar Chief Executive Officer Open Market Disposition -124,529 $233.22–237.88
2026-08-18 Mary Scherer Senior Vice President Open Market Disposition -2,302 $237.39–237.40
2026-08-17 Aaron Alt Chief Financial Officer Open Market Disposition -42,000 $234.55–237.26
2026-08-17 Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Open Market Disposition -7,354 $235.30–237.44
2026-08-17 Jessica Mayer Chief Legal & Compliance Officer Open Market Disposition -29,436 $234.64–237.31
2026-08-17 Stephen Mason Chief Executive Officer of GMPD segment Open Market Disposition -35,000 $234.59–237.26
2026-08-17 Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services Open Market Disposition -11,650 $234.57–237.25
2026-08-14 Jason Hollar Chief Executive Officer Sale to Issuer -103,449 $235.17
2026-08-14 Jason Hollar Chief Executive Officer Other Acquisition +30,616 --
2026-08-14 Aaron Alt Chief Financial Officer Sale to Issuer -30,730 $235.17
2026-08-14 Aaron Alt Chief Financial Officer Other Acquisition +8,079 --
2026-08-14 Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Sale to Issuer -29,759 $235.17
2026-08-14 Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Other Acquisition +7,314 --
2026-08-14 Jessica Mayer Chief Legal & Compliance Officer Sale to Issuer -25,285 $235.17
2026-08-14 Jessica Mayer Chief Legal & Compliance Officer Other Acquisition +6,378 --
2026-08-14 Stephen Mason Chief Executive Officer of GMPD segment Sale to Issuer -25,289 $235.17
2026-08-14 Stephen Mason Chief Executive Officer of GMPD segment Other Acquisition +5,868 --
2026-08-14 Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services Sale to Issuer -10,031 $235.17
2026-08-14 Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services Other Acquisition +2,551 --
2026-08-14 Mary Scherer Senior Vice President Sale to Issuer -1,757 $235.17

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:34 · For reference only, not investment advice and not tailored to your situation.

Cardinal Health discussion 0 comments

Add a comment